NYSE:ELANPharmaceuticals
Why Elanco (ELAN) Is Up 7.3% After Raising 2026 Revenue Guidance On New Product Momentum
In the first quarter of 2026, Elanco Animal Health reported revenue of US$1,371 million versus US$1,193 million a year earlier, while net income eased to US$57 million from US$67 million and earnings per share from continuing operations slipped to US$0.11.
Alongside raising full-year 2026 revenue guidance to a range of US$5.01 billion to US$5.09 billion and issuing second-quarter revenue guidance of US$1,300 million to US$1,325 million, Elanco highlighted innovation-led growth from products...